Medicare Enrolled
Dr. Carlos Encarnacion, M.D.
Medical Oncology · Waco, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Encarnacion from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Encarnacion?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Encarnacion
Dr. Carlos Encarnacion is a medical oncology specialist in Waco, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Encarnacion performed 33,960 Medicare services across 1,284 unique beneficiaries.
Between the years covered by Open Payments, Dr. Encarnacion received a total of $2,668 from 38 pharmaceutical and/or device companies across 69 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Encarnacion is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 27% volume in TX
$2,668 industry payments
Medicare Practice Summary
Medicare Utilization ↗33,960
Medicare services
Top 27% in TX for medical oncology
1,284
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,787 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
21,420 | $0 | $5 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
4,800 | $0 | $5 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,700 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
976 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
751 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
555 | $8 | $36 |
| Anti-nausea injection (Aloxi/palonosetron) | 470 | $1 | $114 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
400 | $62 | $250 |
| Injection, granisetron hydrochloride, 100 mcg | 400 | $0 | $24 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
303 | $93 | $368 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
202 | $97 | $707 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
180 | $12 | $108 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
121 | $22 | $157 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
84 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
84 | $6 | $34 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
79 | $9 | $96 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
74 | $21 | $161 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
61 | $47 | $313 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
57 | $49 | $344 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
49 | $112 | $565 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
48 | $1 | $7 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
34 | $2 | $19 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
25 | $53 | $821 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
25 | $10 | $75 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
18 | $174 | $1,067 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
17 | $15 | $100 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $65 | $372 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
13 | $43 | $686 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
64.5% high complexity
28.8% medium
6.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,668
Total received (2018-2024)
Avg $381/year across 7 years
Bottom 44% in TX for medical oncology
38
Companies
69
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,615 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$53 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$802
2023
$465
2022
$258
2021
$25
2020
$31
2019
$236
2018
$850
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Puma Biotechnology, Inc.
$350
Novartis Pharmaceuticals Corporation
$221
Merck Sharp & Dohme Corporation
$185
E.R. Squibb & Sons, L.L.C.
$181
Adaptive Biotechnologies Corporation
$170
Medtronic, Inc.
$160
AstraZeneca Pharmaceuticals LP
$154
Mirati Therapeutics, Inc.
$130
Clovis Oncology, Inc.
$110
Taiho Oncology, Inc.
$98
Janssen Biotech, Inc.
$73
Lilly USA, LLC
$71
PharmaEssentia USA Corporation
$64
Kite Pharma, Inc.
$63
Myriad Genetic Laboratories, Inc.
$62
Merck Sharp & Dohme LLC
$57
GENZYME CORPORATION
$55
Regeneron Healthcare Solutions, Inc.
$45
Tempus AI, Inc
$36
Medinc of Texas
$36
GlaxoSmithKline, LLC.
$32
Seagen Inc.
$30
Celgene Corporation
$26
Deciphera Pharmaceuticals Inc.
$25
TAIHO ONCOLOGY, INC.
$22
Integra LifeSciences Corporation
$22
Incyte Corporation
$21
SOBI, INC
$20
PFIZER INC.
$19
Stemline Therapeutics Inc.
$19
Blueprint Medicines Corporation
$17
Eisai Inc.
$16
Astellas Pharma US Inc
$16
EMD Serono, Inc.
$13
Medtronic Vascular, Inc.
$13
Acrotech Biopharma LLC
$12
Ipsen Biopharmaceuticals, Inc
$12
Gilead Sciences, Inc.
$12
Top 3 companies account for 28.3% of total payments
Associated products mentioned in payments ›
ADCETRIS · AUGTYRO · AYVAKIT · BELEODAQ · BESREMI · BLENREP · CABLIVI · DARZALEX · ELREXFIO · Endurant · Fabhalta · IMBRUVICA · IMFINZI · Integra · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · Lenvima · Lonsurf · MONJUVI · Nerlynx · OJJAARA · ONYX FRONTIER · OPDIVO · Orserdu · PADCEV · PRECISETUMOR · PROMACTA · QINLOCK · REBLOZYL · Rubraca · SARCLISA · SOMATULINE DEPOT · TECVAYLI · VONJO · Yescarta · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $8 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
5
Per 100K population
1.9
County median income
$63,888
Nearest hospital
ASCENSION PROVIDENCE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Encarnacion is a mixed practice specialist, with above-average Medicare volume (top 27% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Encarnacion experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Encarnacion performed 21,420 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Encarnacion receive payments from pharmaceutical companies?
Yes. Dr. Encarnacion received a total of $2,668 from 38 companies across 69 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Encarnacion's costs compare to other medical oncologists in Waco?
Dr. Encarnacion's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Encarnacion) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Waco
Browse medical oncologists in Waco ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
Puma Biotechnology, Inc. Payments to Doctors
See all physicians who received payments from Puma Biotechnology, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology